603811 Stock Overview
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for 603811 from our risk checks.
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.16 |
| 52 Week High | CN¥11.43 |
| 52 Week Low | CN¥5.78 |
| Beta | 0.36 |
| 11 Month Change | 9.38% |
| 3 Month Change | 32.04% |
| 1 Year Change | -24.86% |
| 33 Year Change | -24.19% |
| 5 Year Change | -13.25% |
| Change since IPO | 38.16% |
Recent News & Updates
Recent updates
Shareholder Returns
| 603811 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -1.9% | -5.2% | -4.1% |
| 1Y | -24.9% | -6.7% | 3.8% |
Return vs Industry: 603811 underperformed the CN Pharmaceuticals industry which returned -6.7% over the past year.
Return vs Market: 603811 underperformed the CN Market which returned 3.8% over the past year.
Price Volatility
| 603811 volatility | |
|---|---|
| 603811 Average Weekly Movement | 5.5% |
| Pharmaceuticals Industry Average Movement | 7.2% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 603811 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603811's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1966 | 738 | Chunjian Zhao | www.chengyipharma.com |
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. produces and sells APIs, injections, capsules, tablets, pharmaceutical intermediates in China. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Fundamentals Summary
| 603811 fundamental statistics | |
|---|---|
| Market cap | CN¥2.64b |
| Earnings (TTM) | CN¥166.02m |
| Revenue (TTM) | CN¥732.68m |
16.1x
P/E Ratio3.6x
P/S RatioIs 603811 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603811 income statement (TTM) | |
|---|---|
| Revenue | CN¥732.68m |
| Cost of Revenue | CN¥243.10m |
| Gross Profit | CN¥489.58m |
| Other Expenses | CN¥323.56m |
| Earnings | CN¥166.02m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.51 |
| Gross Margin | 66.82% |
| Net Profit Margin | 22.66% |
| Debt/Equity Ratio | 24.9% |
How did 603811 perform over the long term?
See historical performance and comparison